Rocky Mountain spotted fever in Brazil;A Febre Maculosa no Brasil

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 27, Issue 6, 2010, Pages 461-466

  De Sá Del Fiol, Fernando ^a   Junqueira, Fábio Miranda ^a   Da Rocha, Maria Carolina Pereira ^a   De Toledo, Maria Inês ^a   Filho, Silvio Barberato ^a  

^a UNIVERSITY OF SOROCABA   (Brazil)

Author keywords

Brazil; Disease notification; Rocky Mountain spotted fever

Indexed keywords

ANTIBIOTICS; BACTERIAL DISEASE; BONE; CHILD HEALTH; DENTITION; DISEASE TREATMENT; HEALTH CARE; MORTALITY;

BRAZIL;

EID: 77955726099     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892010000600008     Document Type: Article

References (45)

1. Harden VA. Rocky Mountain spotted fever: history of a twentieth century disease. Baltimore: Johns Hopkins; 1990.
2. Ricketts HT. Some aspects of Rocky Mountain spotted fever as shown by recent investigations. 1909. Rev Infect Dis. 1991;13(6):1227-1240
3. Ricketts HT. A micro-organism which apparently has a specific relationship to Rocky Mountain spotted fever. JAMA. 1909;52:379-380
4. Howard Taylor Ricketts. Science (Washington). 1910;32(826): 585-587
5. Dias E, Martins AV. Spotted fever in Brazil. A summary. Am J Trop Med. 1939;19(1):103-108
6. Xu WB, Raoult D. Taxonomic relationships among spotted fever group rickettsiae as revealed by antigenic analysis with monoclonal antibodies. J Clin Microbiol. 1998;36(4):887-96.
7. Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect Dis. 2007;7(11): 724-732
8. Lemos ERS. Rickettsial diseases in Brazil. Virus Rev Res. 2002;7(1): 7-16.
9. Lemos ERS, Alvarenga FB, Cintra ML, Ramos MC, Paddock CD, Ferebee TL, et al. Spotted fever in Brazil: a seroepide-miological study and description of clinical cases in an endemic area in the State of São Paulo. Am J Trop Med Hyg. 2001;65(4):329-334
10. de Lemos ER, Machado RD, Coura JR, Guimarães MA, Freire NM, Amorim M, et al. Epidemiological aspects of the Brazilian spotted fever: seasonal activity of ticks collected in an endemic area in São Paulo, Brasil. Rev Soc Bras Med Trop. 1997;30(3):181-185
11. a ed. Brasília: Ministério da Saúde; 2005.
12. Labruna MB, Kasai N, Ferreira F, Faccini JL, Gennari SM. Seasonal dynamics of ticks (Acari: Ixodidae) on horses in the State of São Paulo, Brazil. Vet Parasitol. 2002;105(1):65-77.
13. Brasil, Ministério da Saúde. Tabela de óbitos de febre maculosa. Brasil, Grandes Regiões e Unidades Federadas. 1989-2009. Disponível em: portal.saude.gov.br/portal/saude/profissional/area.cfm?id- area=1555. Acessado em 24 de maio de 2010.
14. Abramson JS, Givner LB. Rocky Mountain spotted fever. Pediatr Infect Dis J. 1999;18(6):539-540
15. São Paulo, Secretaria de Vigilância Epidemiológica. Incidência, óbitos e taxa de letalidade de Febre Maculosa, por ano no estado de São Paulo - 1985 a 2009. Disponível em: cve.saude.sp.gov.br/htm/zoo/fm-i8503.htm. Acessado em 13 de agosto de 2009.
16. Chen LF, Sexton DJ. What's new in Rocky Mountain spotted fever? Infect Dis Clin North Am. 2008;22(3):415-432
17. Walker DH, Valbuena GA, Olano JP. Pathogenic mechanisms of diseases caused by Rickettsia. Ann N Y Acad Sci. 2003;990:1-11.
18. Trabulsi LR, Alterthum F. Microbiologia. São Paulo: Atheneu; 2004.
19. Mansueto P, Vitale G, Di Lorenzo G, Arcoleo F, Mansueto S, Cillari E. Immunology of human rickettsial diseases. J Biol Regul Homeos Agent. 2008; 22(2):131-139
20. Valbuena G, Feng HM, Walker DH. Mechanisms of immunity against rick-ettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect. 2002; 4(6): 625-633
21. Kaplowitz LG, Robertson GL. Hyponatremia in Rocky Mountain spotted fever: role of antidiuretic hormone. Ann Intern Med. 1983;98(3):334-335
22. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150 (4):480-488
23. Rao AK, Schapira M, Clements ML, Niewiarowski S, Budzynski AZ, Schmaier AH, et al. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med. 1988;318(16):1021-1028
24. Mandell GL, Bennett JE, Dolin R. Principles and practices of infectious diseases. New York: Churchill Livingstone; 1995.
25. Batista RS, Gomes AP, Santos SS, Almeida LC, Figueiredo CES, Pacheco SJB. Manual de infectologia. Rio de Janeiro: Revinter; 2003.
26. Kaplowitz LG, Lange JV, Fischer JJ, Walker DH. Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever. Arch Intern Med. 1983;143(6): 1149-1151
27. Walker DH. Rocky Mountain spotted fever: a disease in need of microbiological concern. Clin Microbiol Rev. 1989; 2(3):227-240
28. São Paulo, Secretaria Estadual de Saúde do Estado de São Paulo, Divisão de Zoonoses. Informe Técnico. Febre ma- culosa brasileira. Disponível em: ftp.cve.saude.sp.gov.br/doc-tec/ZOO/ INF-MACULOSA.pdf. Acessado em 26 de junho de 2009.
29. Donohue JF. Lower respiratory tract involvement in Rocky Mountain spotted fever. Arch Intern Med. 1980;140(2): 223-227
30. Tavares W, Marinho LAC. Rotinas de diagnóstico e tratamento das doenças infecciosas e parasitárias. 2a ed. São Paulo: Atheneu; 2007.
31. Tzianabos T, Anderson BE, McDade JE. Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology. J Clin Microbiol. 1989;27(12):2866-2868
32. Rolain JM, Maurin M, Vestris G, Raoult D. In vitro susceptibilities of 27 rick- ettsiae to 13 antimicrobials. Antimicrob Agents Chemother. 1998;42(7):1537-1541
33. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. 2001;184(11):1437-1444
34. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995;52(5):405-413
35. Fishbein DB, Frontini MG, Giles R, Vernon LL. Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988. Ann N Y Acad Sci. 1990;590: 246-247
36. Ormsbee RA, Parker H, Pickens EG. The comparative effectiveness of aureomycin, terramycin, chloramphenicol, erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos. J Infect Dis. 1955;96(2):162-167
37. Raoult D, Roussellier P, Vestris G, Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J Infect Dis. 1987;155 (5):1059-1062
38. American Academy of Pediatrics. Rocky Mountain spotted fever. Em: Pickering LK, ed. Report of the committee on infectious diseases. 26th ed. Elk Grove Village: American Academy of Pediatrics,. 2003.
39. Masters EJ, Oslon GS, Weiner SJ, Paddock CD. Rocky mountain spotted fever: a clinician's dilemma. Arch Intern Med. 2003;163(7):769-774
40. Purvis JJ, Edwards MS. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J. 2000;19(9): 871-874
41. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill. 2001.
42. Herbert WN, Seeds JW, Koontz WL, Cefalo RC. Rocky Mountain spotted fever in pregnancy: differential diagnosis and treatment. South Med J. 1982;75(9): 1063-1066
43. Markley KC, Levine AB, Chan Y. Rocky Mountain spotted fever in pregnancy. Obstet Gynecol. 1998;91(5 Pt 2):860.
44. Stallings SP. Rocky Mountain spotted fever and pregnancy: a case report and review of the literature. Obstet Gynecol Surv. 2001;56(1):37-42.
45. Kenyon RH, Williams RG, Oster CN, Pedersen CE Jr. Prophylactic treatment of Rocky Mountain spotted fever. J Clin Microbiol. 1978;8(1):102-104